DolCas-Tenshi Bioceuticals believe they have developed a next-generation curcumin with features that set it apart from its current competitors. Charlotte Bastiaanse, associate editor at Vitafoods Insights, talks to Dr Shavon Jackson-Michel, director of medical and scientific affairs at DolCas-Tensi Bioceuticals, about Curcugen – highlighting key features and preclinical data.
If you do like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it.
 |
 |
 |
